From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease
<p dir="ltr">Type 2 Diabetes (T2D) and Alzheimer’s Disease (AD) share common risk factors that can be seen through T2D nearly doubling an individual’s likelihood of developing AD. Some AD patients show signs of metabolic dysfunction as well. This review focuses on the potential mecha...
محفوظ في:
| المؤلف الرئيسي: | Ahmad Raza (18205961) (author) |
|---|---|
| مؤلفون آخرون: | Shafaq Saleem (22934654) (author), Samar Imran (22997221) (author), Sarah Rahman (4568125) (author), Muhammad Haroon (7830661) (author), Azeen Razzaq (22997224) (author), Ahmad Hussain (22997227) (author), Javed Iqbal (2121922) (author), Brijesh Sathian (479264) (author) |
| منشور في: |
2025
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Mitochondrial dysfunction: A notable contributor to the progression of Alzheimer's and Parkinson's disease
حسب: Abolaji Samson Olagunju (16855185)
منشور في: (2023) -
Glycation in Alzheimer’s Disease and Type 2 Diabetes: The Prospect of Dual Drug Approaches for Therapeutic Interventions
حسب: Sama Ayoub (15430987)
منشور في: (2025) -
Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer’s Disease
حسب: Sanaa Sharari (12561952)
منشور في: (2023) -
Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls
حسب: Daniel Erskine (3471959)
منشور في: (2019) -
Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension
حسب: Yousef, Hibba
منشور في: (2023)